Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of PXR activation on glucose, cholesterol and hormone balance
2010-023662-47Phase 4Completed
- Sponsor
- Oulu University Hospital
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rifampicin, sponsored by Oulu University Hospital. Primary endpoints: Changes in plasma glucose during oral glucose tolerance test, Changes in serum PYY during oral glucose tolerance test and 4 more. Started Nov 2010; status: completed.
02
Drugs
rifampicin
Beyond the preview
Go deeper on 2010-023662-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023662-47.